DR. PAMELA HILLYARD CHENEY, M.D.

WELLESLEY, MA

Research Active
Surgery NPI registered 21+ years 20 publications 1987 – 2024 NPI: 1700883527
Disease Models, AnimalDouble-Blind MethodCaliforniaAntiviral AgentsBreast NeoplasmsEmergency Medical ServicesAntibodies, ViralMacaca mulattaMastectomy, SegmentalRNA, Double-StrandedHerpesvirus 4, HumanFatigue Syndrome, ChronicSimian Acquired Immunodeficiency SyndromePoly I-CPoly U

Practice Location

416 WESTON RD
WELLESLEY, MA 02482

Phone: (781) 489-5146

What does PAMELA CHENEY research?

Dr. Cheney studies a wide range of medical topics, with a strong emphasis on cancer diagnosis and treatment, as well as emergency care protocols. In her cancer research, she utilizes advanced imaging technology to identify tumor margins during breast-conserving surgeries, which assists in ensuring all cancerous tissue is removed. She also investigates new cancer treatment options, such as the drug ARTIK-52 that targets specific prostate and breast cancer cells while sparing healthy cells. Additionally, Dr. Cheney explores methods to improve emergency medical responses, including how to effectively manage patients experiencing nausea or agitation during transport.

Key findings

  • In a study on hyperspectral microscopy, Dr. Cheney's team accurately differentiated between cancerous and non-cancerous breast tissue types, potentially improving surgical outcomes.
  • The drug ARTIK-52 demonstrated effectiveness in killing androgen receptor-positive prostate and breast cancer cells without affecting healthy cells, indicating its potential as a targeted treatment.
  • Patients receiving ondansetron during emergency transport experienced an average reduction in nausea scores of 24.6 points, showing superior effectiveness over normal saline alone.
  • In chronic fatigue syndrome patients, the drug poly(I)-poly(C12U) led to significant improvements in functioning, treadmill performance, and cognitive impairment after 24 weeks of treatment.

Frequently asked questions

Does Dr. Cheney study cancer?
Yes, Dr. Cheney focuses on breast and prostate cancer, exploring innovative imaging techniques for detection and targeted drug treatments.
What treatments has Dr. Cheney researched for nausea?
Dr. Cheney has researched ondansetron, finding it significantly reduces nausea in patients during emergency medical transportation.
Is Dr. Cheney's work relevant to chronic fatigue syndrome?
Yes, her research includes effective treatments for chronic fatigue syndrome, with positive results from the drug poly(I)-poly(C12U) improving patient quality of life.
How does Dr. Cheney's work help patients in emergency situations?
Her studies have shown better protocols for managing agitation and nausea in emergency medical settings, which can enhance patient comfort and outcomes.
What imaging technique does Dr. Cheney use for cancer detection?
Dr. Cheney employs hyperspectral dark-field microscopy, a method that helps accurately distinguish cancerous tissues in surgical samples.

Publications in plain English

Hyperspectral dark-field microscopy of human breast lumpectomy samples for tumor margin detection in breast-conserving surgery.

2024

Journal of biomedical optics

Hwang J, Cheney P, Kanick SC, Le HND, McClatchy DM +8 more

Plain English
This study focused on using a new imaging technique called hyperspectral dark-field microscopy to identify different types of tissue, especially cancerous tissues, in breast samples taken during breast-conserving surgeries. Researchers found that they could accurately distinguish between various tissue types and specific cancer subtypes, like invasive ductal carcinoma and invasive mucinous carcinoma, using two different analysis methods. This is important because it could lead to better detection of cancer margins during surgery, helping to ensure that no cancerous tissue is left behind. Who this helps: This benefits breast cancer patients undergoing surgery.

PubMed

FACT is a sensor of DNA torsional stress in eukaryotic cells.

2017

Nucleic acids research

Safina A, Cheney P, Pal M, Brodsky L, Ivanov A +10 more

Plain English
This study examined how a protein called FACT detects changes in DNA structure that can happen when DNA is twisted too much, which may lead to problems like cancer. Researchers found that when a drug called curaxin interacts with DNA, it causes changes in the DNA that FACT can recognize, triggering a protective response in cells. Specifically, they showed that FACT binds strongly to areas of DNA that are changing form, leading to the activation of a protein called p53 that helps prevent DNA damage. Who this helps: This helps patients by providing insights into potential cancer treatments and improving understanding of DNA repair mechanisms.

PubMed

ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin.

2016

Cell cycle (Georgetown, Tex.)

Fleyshman D, Cheney P, Ströse A, Mudambi S, Safina A +8 more

Plain English
This study looked at a new drug called ARTIK-52 and its effects on prostate and breast cancer cells. Researchers found that ARTIK-52 can kill cancer cells that have androgen receptors (AR) by causing damage to their DNA, while leaving healthy cells unharmed. This specificity means ARTIK-52 has potential as a targeted treatment for certain types of breast and prostate cancers. Who this helps: Patients with prostate and breast cancer that express androgen receptors.

PubMed

Recovery of precision grasping after motor cortex lesion does not require forced use of the impaired hand in Macaca mulatta.

2014

Experimental brain research

Darling WG, Morecraft RJ, Rotella DL, Pizzimenti MA, Ge J +8 more

Plain English
Researchers studied how monkeys could regain their ability to grasp small objects with a hand that had suffered motor cortex damage. After the injury, the monkeys initially used their stronger hand but began to use the injured hand again after about three weeks, demonstrating improved control and precision in grasping, though not quite at pre-injury levels. This finding is important because it shows that recovery of hand function can happen naturally, without needing to force the use of the injured hand. Who this helps: This helps patients recovering from hand injuries and their doctors.

PubMed

The use of chemical restraints reduces agitation in patients transported by emergency medical services.

2012

The Journal of emergency medicine

Weiss S, Peterson K, Cheney P, Froman P, Ernst A +1 more

Plain English
This study looked at how using a medication called midazolam along with physical restraints can help calm agitated patients during ambulance transport. Researchers found that patients who received midazolam saw their agitation decrease more significantly, with an average decrease in agitation scores of -17 compared to -7 for those who only had physical restraints. This research is important because it shows that adding this medication can make transport safer for both patients and emergency responders. Who this helps: This helps patients in emergency situations and the medical staff transporting them.

PubMed

Enhanced pulmonary arteriopathy in simian immunodeficiency virus-infected macaques exposed to morphine.

2012

American journal of respiratory and critical care medicine

Spikes L, Dalvi P, Tawfik O, Gu H, Voelkel NF +3 more

Plain English
The study looked at how morphine and HIV infection affect the lungs of macaques, focusing on serious lung damage known as pulmonary arterial hypertension (PAH). The researchers found that macaques infected with simian immunodeficiency virus (SIV) and treated with morphine had more severe lung problems, including complex lesions, compared to those only infected with SIV or treated with morphine without infection. Specifically, they noted significant changes in the lung's blood vessels that could lead to serious health issues. Who this helps: This research benefits patients with HIV, especially those who also use intravenous drugs.

PubMed

Ondansetron oral dissolving tablets are superior to normal saline alone for prehospital nausea.

2012

Prehospital emergency care

Fullerton L, Weiss SJ, Froman P, Oglesbee S, Cheney P

Plain English
Researchers studied the effectiveness of ondansetron oral dissolving tablets compared to normal saline in reducing nausea for patients during emergency medical transport. They found that patients who received ondansetron reported an average improvement in their nausea scores of 24.6 points on a scale from 0 to 100, indicating that this medication significantly eased their discomfort, while saline alone showed no such effect. This matters because effective treatment for nausea can lead to better patient comfort and outcomes during emergencies. Who this helps: This helps patients experiencing nausea during emergency medical situations.

PubMed

Impact of a restraint training module on paramedic students' likelihood to use restraint techniques.

2008

Prehospital emergency care

Campbell M, Weiss S, Froman P, Cheney P, Gadomski D +2 more

Plain English
This study looked at how a one-hour training session on restraint techniques affected paramedic students' knowledge and their willingness to use those techniques in emergencies. The students' understanding improved, with their average quiz scores rising from 66% to 85% after the training. However, their likelihood of using restraints didn't change much, staying around 56 out of 100 before and after the training. Who this helps: This benefits paramedic students and ultimately enhances patient safety during emergency care.

PubMed

Safety and compliance with an emergency medical service direct psychiatric center transport protocol.

2008

The American journal of emergency medicine

Cheney P, Haddock T, Sanchez L, Ernst A, Weiss S

Plain English
This study looked at how well emergency medical services (EMS) followed a new protocol that allows paramedics to take patients directly to psychiatric facilities instead of the emergency department (ED). Out of 174 patients transported, the protocol worked effectively in 96% of cases, but there were 51 instances (about 29%) where EMS did not fully comply with the requirements. This is important because it shows that while the protocol is generally safe, there needs to be better adherence to important guidelines to ensure patient safety. Who this helps: This helps patients experiencing psychiatric emergencies and the EMS team treating them.

PubMed

Neuropathogenesis of lentiviral infection in macaques: roles of CXCR4 and CCR5 viruses and interleukin-4 in enhancing monocyte chemoattractant protein-1 production in macrophages.

2002

The American journal of pathology

Hicks A, Potula R, Sui YJ, Villinger F, Pinson D +11 more

Plain English
This research examined how certain types of lentivirus infections affect the brains of two types of macaques. The study found that rhesus macaques, compared to pig-tailed macaques, are more vulnerable to brain disease caused by a specific strain of the virus known as CXCR4 (X4) tropic viruses, which produces more of a chemical called MCP-1. This increased MCP-1 production is linked to the presence of interleukin-4, suggesting that this factor plays an important role in the development of brain disease from these infections. Who this helps: This information benefits researchers and healthcare providers who work with patients affected by similar viral infections.

PubMed

[Psychosocial problems and the office visit].

2000

Duodecim; laaketieteellinen aikakauskirja

Väisänen L, Cheney P

PubMed

Update on emerging infections from the Centers for Disease Control and Prevention: fatal human plague--Arizona and Colorado, 1996.

1998

Annals of emergency medicine

Cheney P

PubMed

Gradient of microglial activation in the brain of SIV infected macaques.

1998

Journal of neuro-AIDS

Berman NE, Sheffield LG, Purcell J, Joag SV, Narayan O +1 more

Plain English
Researchers studied the brains of macaques infected with different strains of SIV to see how the virus affects brain cells. They found that one infected macaque showed severe brain inflammation and neuron loss, while those infected with other strains did not exhibit these severe changes but still showed signs of microglial activation. This matters because it helps understand how different types of the virus impact brain health, which could lead to better treatments for brain-related issues in HIV patients. Who this helps: This helps patients with HIV and their doctors in managing and understanding brain health.

PubMed

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome.

1994

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Strayer DR, Carter WA, Brodsky I, Cheney P, Peterson D +5 more

Plain English
This study looked at a new drug called poly(I).poly(C12U) in 92 patients with chronic fatigue syndrome (CFS), a condition that causes extreme tiredness and cognitive difficulties. After 24 weeks, patients taking the drug showed significant improvements: they had better overall functioning, could perform more work on a treadmill, found it easier to carry out daily activities, and had less cognitive impairment compared to those on a placebo. These findings are important because they suggest that poly(I).poly(C12U) can help improve the quality of life for people suffering from CFS. Who this helps: This helps patients with chronic fatigue syndrome.

PubMed

Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome.

1994

In vivo (Athens, Greece)

Suhadolnik RJ, Reichenbach NL, Hitzges P, Adelson ME, Peterson DL +5 more

Plain English
This study looked at how a treatment called poly(I)-poly(C12U) affects pathways in the body related to viral responses in people with chronic fatigue syndrome (CFS). Researchers found that before treatment, participants had higher levels of certain biological markers compared to healthy individuals. After taking poly(I)-poly(C12U), many patients showed a significant decrease in these markers, which was linked to improvements in cognitive function. This matters because it suggests that the treatment could help manage symptoms in CFS patients. Who this helps: Patients with chronic fatigue syndrome.

PubMed

Early management and physiologic changes in crush syndrome.

1994

Critical care nursing quarterly

Cheney P

Plain English
This study looks at crush syndrome, which happens when a person suffers from severe injuries due to being crushed. Researchers found that these injuries can lead to several serious problems, like low blood volume, kidney failure, and muscle breakdown, that require careful management to prevent further complications. Early and effective care is crucial in reducing risks and improving patient outcomes. Who this helps: This helps patients who have experienced crush injuries and the doctors treating them.

PubMed

Chemical immobilization and killing of intra-aural roaches: an in vitro comparative study.

1993

Annals of emergency medicine

Leffler S, Cheney P, Tandberg D

Plain English
In this study, researchers tested different substances to see which one worked best to quickly immobilize and kill cockroaches found in people's ears. They discovered that microscope immersion oil was the most effective, killing cockroaches in an average of 27.2 seconds, while other tested substances took over 40 seconds to be effective. This finding is important because it identifies a faster and more effective treatment option for a potentially uncomfortable and embarrassing situation for patients. Who this helps: This helps patients who experience cockroaches in their ears.

PubMed

Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome.

1992

Archives of internal medicine

Levine PH, Jacobson S, Pocinki AG, Cheney P, Peterson D +5 more

Plain English
This study looked at chronic fatigue syndrome (CFS) during outbreaks in Nevada and California. Researchers found that after three years, nearly all participants were able to return to their normal activities, and none of the viruses tested—like Epstein-Barr and human T-lymphotropic viruses—were linked to the condition. Interestingly, giardiasis (a gut infection) seemed to trigger one of the four outbreaks studied, but the causes of the other three are still unknown. This research is important because it helps clarify the nature of CFS and suggests that different factors may cause different outbreaks. Who this helps: This helps patients with chronic fatigue syndrome and their doctors understand the illness better.

PubMed

Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.

1987

Journal of immunology (Baltimore, Md. : 1950)

Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P +3 more

Plain English
This study looked at natural killer (NK) cells, which help fight viral infections, in 41 patients with chronic fatigue syndrome (CFS) and compared them to 23 healthy individuals. The researchers found that most CFS patients had very few of a specific type of NK cell that is usually abundant in healthy people, while maintaining normal levels of a different, less common type of NK cell. This means CFS patients struggle to effectively kill infected cells, which could explain some of their symptoms. Who this helps: This information is valuable for patients with chronic fatigue syndrome and their doctors, as it provides insights into the immune system's role in the condition.

PubMed

Methoxsalen is a potent inhibitor of the metabolism of caffeine in humans.

1987

Clinical pharmacology and therapeutics

Mays DC, Camisa C, Cheney P, Pacula CM, Nawoot S +1 more

Plain English
This study looked at how methoxsalen, a medication used for psoriasis, affects the way the body processes caffeine. The researchers found that after taking methoxsalen, the rate at which caffeine was cleared from the body dropped significantly, from 110 ml/min to just 34 ml/min, and the time it took for caffeine to be eliminated increased from 5.6 hours to 57 hours. This is important because it means that methoxsalen can slow down the metabolism of other drugs as well, which could affect how patients respond to their medications. Who this helps: This research helps patients taking methoxsalen, especially those with psoriasis, by informing them and their doctors about possible interactions with caffeine and other drugs.

PubMed

Frequent Co-Authors

Amy Ernst D Peterson Alfiya Safina Katerina Gurova Phil Froman Micha Campbell Steven Weiss P Salvato C Thompson M Loveless

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.